Nelonemdaz-potassium-Salfaprodil-DataSheet-生命科學(xué)試劑-MedChemExpress_第1頁(yè)
Nelonemdaz-potassium-Salfaprodil-DataSheet-生命科學(xué)試劑-MedChemExpress_第2頁(yè)
Nelonemdaz-potassium-Salfaprodil-DataSheet-生命科學(xué)試劑-MedChemExpress_第3頁(yè)
Nelonemdaz-potassium-Salfaprodil-DataSheet-生命科學(xué)試劑-MedChemExpress_第4頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Hotline:400-820-3792Inhibitors?ScreeningLibraries?Proteinswww.MedChemENelonemdazpotassiumCat.No.:HY-106408ACASNo.:916214-57-8Synonyms:Salfaprodil;Neu2000potassium分?式:C??H?F?KNO?分?量:421.31作?靶點(diǎn):iGluR作?通路:MembraneTransporter/IonChannel;NeuronalSignaling儲(chǔ)存?式:4°C,sealedstorage,awayfrommoisture*Insolvent:-80°C,6months;-20°C,1month(sealed

storage,awayfrommoisture)溶解性數(shù)據(jù)體外實(shí)驗(yàn)DMSO:200mg/mL(474.71mM;Needultrasonic)MassSolvent1mg5mg10mgConcentration制備儲(chǔ)備液1mM2.3735mL11.8677mL23.7355mL5mM0.4747mL2.3735mL4.7471mL10mM0.2374mL1.1868mL2.3735mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;?旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。儲(chǔ)備液的保存?式和期限:-80°C,6months;-20°C,1month(sealedstorage,awayfrommoisture)。-80°C儲(chǔ)存時(shí),請(qǐng)?jiān)?個(gè)?內(nèi)使?,-20°C儲(chǔ)存時(shí),請(qǐng)?jiān)?個(gè)?內(nèi)使?。BIOLOGICALACTIVITY?物活性Nelonemdaz(Salfaprodil)potassium?種NR2B選擇性和?競(jìng)爭(zhēng)性的N-甲-D-天冬氨酸(NMDA)受體拮抗劑,也?種?由除劑。Nelonemdazpotassium對(duì)NMDA和?由誘導(dǎo)的細(xì)胞死亡具有出?的神經(jīng)保護(hù)作?。IC50&TargetNMDA[1]1/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemE體外研究Nelonemdazpotassium(10-300μM)showsapparentneuroprotectionagainst300μMN-methyl-d-aspartate(NMDA)atdosesaslowas30μM[1].Nelonemdazpotassium(10-500μM)inhibitstheelectrophysiologicresponseofculturedcorticalneuronsto300μMNMDAinaconcentration-dependentmanner[1].Nelonemdazpotassium(0.1-1μM)producesamarkedreductionofFe2+-inducedneurotoxicity,evenatdosesof0.1to0.3μM[1].Nelonemdazpotassium(0.1-1μM)blocksthedegenerationofneuronsandgliaincorticalcellcultures[1].Nelonemdazpotassium(0-350μM)effectivelyscavengessuperoxideradicals(IC50=63.07±1.44μM),nitricoxide(IC50=155.8±4.88μM),andhydroxylradicals(IC50=58.45±1.74μM)[3].Nelonemdazpotassium(0.78-12.5μM)decreasestheamountofantimycinA-inducedROS/RNSformationinadose-dependentmanner,withanIC50of2.21±0.11μM[3].Nelonemdazpotassium(0.19-12.5μM)inhibitsmalondialdehyde(MDA)formationwithanIC50of2.72±0.26μM[3].Nelonemdazpotassium(0-125μM)effectivelyreducesiron-ascorbate-inducedlipidperoxidation(IC50=24.56±0.07μM)[3].體內(nèi)研究Nelonemdazpotassium(0.5-20mg/kg;i.v.)reducescerebralinfarctevolving24hafter60-minsocclusionofthemiddlecerebralarteryocclusion(MCAO)substantiallyanddosedependently[1].Nelonemdazpotassium(5mg/kg;i.v.)protectswhitemattersuchasaxonsandmyelinaswellasgraymatterfromischemicbraininjury[1].AnimalModel:MaleSprague-Dawleyrats(260to300g)(clipocclusionmodel)[1]Dosage:0.5-20mg/kgAdministration:I.v.administration5minsafterreperfusionResult:Producedalargeneuroprotectiveeffect,withamaximalreductionininfarctvolumeof66%atdosesof2.5to5mg/kg.Notobservedneuronaldamageinthemostvulnerablecorticalareaafteradministrationof5mg/kg.AnimalModel:MaleSprague-Dawleyrats(260to300g)(intraluminalthreadocclusionmodel)[1]Dosage:5mg/kgAdministration:I.v.administration30minsafterreperfusionResult:DidnotchangephysiologicvariablessuchasarterialpH,PCO2,PO2,andhematocrit.Reducedinfarctvolumeevolvinginthecortexandthestriatumsubstantially.Reducedwhitematterdamageinthestriatumandexternalcapsulemarkedly.REFERENCES2/3MasterofBioactiveMolecules—您?邊的抑制劑?師www.MedChemE[1].NishantPV,et,al.AntioxidantPropertiesofNeu2000onMitochondrialFreeRadicalsandOxidativeDamage.ToxicolInVitro.2013Mar;27(2):788-97.[2].GwagBJ,etal.MarkedpreventionofischemicbraininjurybyNeu2000,anNMDAantagonistandantioxidantderivedfromaspirinandsulfasalazine.JCerebBloodFlowMetab.2007Jun;27(6):1142-51.[3].SungIC,et,al.Neu2000,anNR2B-selective,ModerateNMDAReceptorAntagonistandPotentSpinTrappingMoleculeforStroke.DrugNewsPerspect.2010Nov;23(9):549-56.McePdfHeightCaution

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論